Search Ontology:
ChEBI
alpha-L-Araf-(1->2)-[beta-D-Glcp-(1->3)]-alpha-L-Arap
- Term ID
- CHEBI:148831
- Synonyms
-
- (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S)-3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2,5-dihydroxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- alpha-L-arabino-pentofuranosyl-(1->2)-[beta-D-gluco-hexopyranosyl-(1->3)]-alpha-L-arabino-pentopyranose
- alpha-L-arabinofuranosyl-(1->2)-[beta-D-glucopyranosyl-(1->3)]-alpha-L-arabinopyranose
- Araf(a1-2)[Glc(b1-3)]a-Ara
- WURCS=2.0/3,3,2/[a211h-1a_1-5][a211h-1a_1-4][a2122h-1b_1-5]/1-2-3/a2-b1_a3-c1
- Definition
- A trisaccharide consisting of alpha-L-arabinofuranose and alpha-L-arabinopyranose residues joined in sequence by a (1->2) glycosidic bond, and in which a beta-D-glucopyranose residue has been attached to the arabinopyranose residue by a (1->3) glycosidic bond.
- References
-
- GlyTouCan:G27025WD
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
Phenotype
Phenotype resulting from alpha-L-Araf-(1->2)-[beta-D-Glcp-(1->3)]-alpha-L-Arap
Phenotype where environments contain alpha-L-Araf-(1->2)-[beta-D-Glcp-(1->3)]-alpha-L-Arap
Phenotype modified by environments containing alpha-L-Araf-(1->2)-[beta-D-Glcp-(1->3)]-alpha-L-Arap
Human Disease Model